Paul B. Manning, Director, 10% Owner at Taysha Gene Therapies, Inc. (TSHA), bought 228,204 shares at $7.84 ($1.8M) on 2022-02-03, disclosed to the SEC on 2022-02-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.77 | 22,000 | $171K | 9.6% |
| 2 | $7.77 | 45,000 | $350K | 19.6% |
| 3 | $7.77 | 58,000 | $451K | 25.3% |
| 4 | $7.84 | 26,602 | $209K | 11.7% |
| 5 | $7.84 | 26,602 | $209K | 11.7% |
| 6 | $7.84 | 50,000 |
| $392K |
| 22.0% |
| Total | $7.80 avg | 228,204 | $1.8M | 100% |
| Filing → |
| VRCA | BUY | 2025-11-25 | $35.0M | — | Filing → |
| LQDA | SELL | 2025-09-02 | $37.9M | — | Filing → |
| TSHA | BUY | 2025-06-03 | $2.1M | — | Filing → |